Current Edition

Upcoming Events

Advertisement

news

UniQure, with Sale of Plant, Outsources Hemgenix Manufacturing

The gene therapy developer plans to sell its Lexington, Massachusetts, facility to Genezen, a CDMO that specializes in viral vector production. Dive Brief: Un...
Continue Reading →
news

Can Robots Break the Cell Therapy Bottleneck?

A partnership between cell therapy delivery specialist Portal Biotechnologies and precision robotics maker Multiply Labs could address manufacturing hurdles, the CEO...
Continue Reading →
news

Regeneron Gene Therapy Improves Hearing in Two Children

The results add to an early but growing body of evidence suggesting gene therapy may improve outcomes in young kids with a genetic form of deafness. Design Brief:...
Continue Reading →
news

Are you Meeting Safety Standards for Residual Host Cell DNA?

Are you meeting safety standards for residual host cell DNA? To realise the incredible potential of cell and gene therapies, scientists must overcome many challen...
Continue Reading →
news

Cellular Origins Acquires ACTIA Platform IP to Enhance Automated Cell Therapy Manufacturing

Autologous Cell Therapy Industrial Automation (ACTIA) strengthens technology and IP portfolio of Cellular Origins supporting ongoing development and expanding capabi...
Continue Reading →
news

Newcells Biotech Appoints Emile Shaffu as Director of Sales

Key commercial appointment follows a series of executive team changes to support ongoing company expansion. Newcells Biotech (“Newcells”), a leading drug discover...
Continue Reading →
news

CPHI Returns to the Messe Frankfurt in 2025

The Heart of Pharma will return to Europe’s leading pharma manufacturing region The world's largest pharmaceutical event, CPHI Europe, will return to Messe Frankf...
Continue Reading →
news

ELRIG UK and The Protein Society Partner to Advance Protein Sciences in Drug Discovery

Partners to host joint conference on ‘Protein Sciences in Drug Discovery’ inCambridge, UK from 18–19 November 2024 Cambridge, UK and Los Angeles, US, 26 June 2024...
Continue Reading →
news

Samsung Biologics Upgrades Another Production Pact, this Time with Baxter for $223M

On a revised dealmaking spree this year, Korea’s Samsung Biologics is re-tooling its long-running drug manufacturing pact with Baxter Healthcare. The retooled dea...
Continue Reading →
news

Watch Out, GSK. Gilead’s Twice-yearly PrEP Drug Shows 100% Efficacy for HIV Prevention

For the first time, an HIV PrEP drug candidate has shown zero infections in a phase 3 trial. The result came from the PURPOSE 1 trial evaluating Gilead ...
Continue Reading →